We found that the combination of SYCP2 with CDKN2A improved HPV status assessment in HNSCC from 85% with CDKN2A alone to 97% accuracy (Fig. 3E; Supplementary Fig. S8G). This evidence concerns the gene CDKN2A and head and neck squamous cell carcinoma.